Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Thromboelastography (TEG) is a viscoelastic hemostatic assay that measures the visco-elastic properties of blood clot formation. It is mainly used in surgery and anesthesiology. This test is capable of measuring coagulation factor function. Some of the other tests for blood coagulation includes prothrombin time and partial thromboplastin time (aPTT). However, thromboelastography provides information regarding all components of hemostasis such as coagulation and platelet function. Also, TEG offers a particular advantage in diagnosing fibrinolysis. TEG machines are used for carrying out this test.

The global thromboelastography market size is estimated to be valued at US$ 531.8 million in 2020 and is expected to exhibit a CAGR of 7.2% over the forecast period (2020-2027).

Figure 1. Global Thromboelastography Market Value (US$ Mn), by Region, 2020

Thromboelastography Machine  | Coherent Market Insights

Increasing life>

Rising patient population suffering from life>

Figure 2. Global Thromboelastography Market Share (%), by Type, 2020

Thromboelastography Machine  | Coherent Market Insights

Increasing adoption of strategies such as mergers, agreements, and collaborations by key players is expected to drive the market growth over the forecast period

Market players are focused on adoption of inorganic growth strategies such as collaborations and agreements to strengthen their position in the thromboelastography market. For instance, in April 2020, Haemonetics Corporation announced the acquisition of enicor GmbH, a manufacturer of whole blood coagulation testing system – ClotPro. This system is expected to strengthen its product capabilities such as TEG 5000 Hemostasis Analyzer and the TEG 6s Hemostasis Analyzer, and offer better products in the market. The ClotPro system reduces the need for annual pipetting and also eliminates reagent handling issues.

request-sample

Thromboelastography Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 531.8 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 7.2% 2027 Value Projection: US$  863.9 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Standard, RapidTEG, Functional Fibrinogen, Platelet Mapping, Heparinase, Consumables & Disposables.
  • By Application: Cardio-pulmonary Bypass Surgery, Liver Transplantation, Trauma, Obstetrics, Neonatology and Pediatrics, Others.
  • By End User: Hospitals & Clinics, Blood Banks, Academic Institutes, Others.
Companies covered:

Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica

Growth Drivers:
  • Increasing life>
  • Increasing number of surgical procedures
Restraints & Challenges:
  • Limitations of thromboelastography

Thromboelastography Market Restraints

Thromboelastography is a promising and highly sensitive test for identifying underlying coagulopathy following traumatic brain injury. However, the confirmation with conventional coagulation tests (CCTs) is recommended, which is a time consuming and lengthy procedure.

Moreover, for performing a thromboelastography analysis in a laboratory setting, the transportation of blood sample for more than five minutes is required, which is the upper limit for running native blood samples and hence, storage of the blood sample in citrate or heparin becomes necessary. The use of citrate storage has been reported to influence the results of the thromboelastography analysis. Thus, such drawbacks of thromboelastography is expected to hinder the market growth.

 Global Thromboelastography Market – Impact of Coronavirus (Covid-19) Pandemic

COVID-19 infected patients may face a high risk of developing kidney failure, stroke, and other complications associated with blood clot formation. According to the researchers from the University of Colorado Anschutz Medical Campus, Aurora, early thromboelastography (TEG) assay may be useful to identify COVID-19 patients who may need more anticoagulation therapy to prevent complications due to clot formation.

Moreover, it is recommended that all patients with COVID-19 should undergo coagulation studies at admission, as there is significant increase in D-dimer and prothrombin with a decrease in fibrinogen observed in COVID-19 patients who are at high risk (non-survivors at days 10-14). This is expected to accelerate the use of coagulopathy screening test including thromboelastography (TEG) assay and other conventional coagulation tests in the clinical setting.

Increasing prevalence of COVID-19, especially among the patients with existing severe health conditions/disorders, is expected to create a conducive environment for global thromboelastography market growth. For instance, according to the study by Hypertension Research (2020), acute cardiac injury is the most frequently reported cardiovascular abnormality in COVID-19 patients and it occurs in around 8–12% of all COVID-19 patients.

Key Players

Major players operating in the global thromboelastography market include Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica.

Thromboelastography (TEG) is used to measure the visco-elastic properties of blood clot formation. It is a major application in surgery and anesthesiology. Increasing use of TEG machines for blood management has helped in predicting and managing bleeding disorders. It also helps in evaluating the risk for re-operation, which leads to cost saving, as it reduces unnecessary blood component transfusions. This machine has applications in hospitals, blood banks, pharmaceutical, and academic institutes.

Market Dynamics

Rising incidence of surgeries and organ transplant procedures is a major factor that is expected to boost the thromboelastography market growth over the forecast period. For instance, according to U.S. Department of Health and Human Services, 34,770 organ transplants were performed in the U.S in 2017. Rising launch of novel platelet mapping assays and other products is expected to drive the market growth. For instance, in November 2019, Haemonetics Corporation launched the four-channel TEG 6s PlateletMapping ADP & AA assay cartridge. The product is designed for use with TEG 6s Hemostasis Analyzer System.

Key features of the study:

  • This report provides in-depth analysis of the global thromboelastography market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global thromboelastography market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global thromboelastography market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global thromboelastography market

Detailed Segmentation:

  • Global Thromboelastography Market, By Type:
    • Standard
    • RapidTEG
    • Functional Fibrinogen
    • Platelet Mapping
    • Heparinase
    • Consumables & Disposables
  • Global Thromboelastography Market, By Application:
    • Cardio-pulmonary Bypass Surgery
    • Liver Transplantation
    • Trauma
    • Obstetrics
    • Neonatology and Pediatrics
    • Others
  • Global Thromboelastography Market, By End User:
    • Hospitals & Clinics
    • Blood Banks
    • Academic Institutes
    • Others
  • Global Thromboelastography Market, By Region:
    • North America
      • By Type:
        • Standard
        • RapidTEG
        • Functional Fibrinogen
        • Platelet Mapping
        • Heparinase
        • Consumables & Disposables
      • By Application
        • Cardio-pulmonary Bypass Surgery
        • Liver Transplantation
        • Trauma
        • Obstetrics
        • Neonatology and Pediatrics
        • Others
      • By End User:
        • Hospitals & Clinics
        • Blood Banks
        • Academic Institutes
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Type:
        • Standard
        • RapidTEG
        • Functional Fibrinogen
        • Platelet Mapping
        • Heparinase
        • Consumables & Disposables
      • By Application
        • Cardio-pulmonary Bypass Surgery
        • Liver Transplantation
        • Trauma
        • Obstetrics
        • Neonatology and Pediatrics
        • Others
      • By End User:
        • Hospitals & Clinics
        • Blood Banks
        • Academic Institutes
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type:
        • Standard
        • RapidTEG
        • Functional Fibrinogen
        • Platelet Mapping
        • Heparinase
        • Consumables & Disposables
      • By Application
        • Cardio-pulmonary Bypass Surgery
        • Liver Transplantation
        • Trauma
        • Obstetrics
        • Neonatology and Pediatrics
        • Others
      • By End User:
        • Hospitals & Clinics
        • Blood Banks
        • Academic Institutes
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type:
        • Standard
        • RapidTEG
        • Functional Fibrinogen
        • Platelet Mapping
        • Heparinase
        • Consumables & Disposables
      • By Application
        • Cardio-pulmonary Bypass Surgery
        • Liver Transplantation
        • Trauma
        • Obstetrics
        • Neonatology and Pediatrics
        • Others
      • By End User:
        • Hospitals & Clinics
        • Blood Banks
        • Academic Institutes
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type:
        • Standard
        • RapidTEG
        • Functional Fibrinogen
        • Platelet Mapping
        • Heparinase
        • Consumables & Disposables
      • By Application
        • Cardio-pulmonary Bypass Surgery
        • Liver Transplantation
        • Trauma
        • Obstetrics
        • Neonatology and Pediatrics
        • Others
      • By End User:
        • Hospitals & Clinics
        • Blood Banks
        • Academic Institutes
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type:
        • Standard
        • RapidTEG
        • Functional Fibrinogen
        • Platelet Mapping
        • Heparinase
        • Consumables & Disposables
      • By Application
        • Cardio-pulmonary Bypass Surgery
        • Liver Transplantation
        • Trauma
        • Obstetrics
        • Neonatology and Pediatrics
        • Others
      • By End User:
        • Hospitals & Clinics
        • Blood Banks
        • Academic Institutes
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Haemonetics Corporation*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Instrumentation Laboratory
    • Framar Hemologix srl
    • Medirox AB
    • Diagnostica Stago
    • Life Diagnostica

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Product Launch/Approvals
    • Regulatory Scenario
    • Acquisition and Collaboration Scenario
    • Key Developments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Thromboelastography Market – Impact of Coronavirus (Covid-19) Pandemic
    • Post COVID-19 Market Scenario
    • Demand Supply Impact
    • Economic Impact
    • Clinical Trial Analysis
  5. Global Thromboelastography Market, By Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Standard
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • RapidTEG
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Functional Fibrinogen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Platelet Mapping
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Heparinase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Consumables and Disposables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Thromboelastography Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cardio-pulmonary Bypass Surgery
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Liver Transplantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Trauma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Obstetrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Neonatology and Pediatrics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Thromboelastography Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Blood Banks
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Thromboelastography Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Haemonetics Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Instrumentation Laboratory
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Framar Hemologix srl
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medirox AB
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Diagnostica Stago
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Life Diagnostica
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 31 market data tables and 24 figures on "Thromboelastography Market” - Global forecast to 2027

Frequently Asked Questions

The global thromboelastography market size is estimated to be valued at US$ 531.8 million in 2020 and is expected to exhibit a CAGR of 7.2% between 2020 and 2027.
Increasing lifestyle associated diseases and incidence of chronic blood disorders, and increasing number of surgical procedures are driving the thromboelastography market growth.
The Hospitals & Clinics segment is expected to be the leading end user segment in the thromboelastography market during the forecast period (2020-2027).
North America thromboelastography market is expected to generate highest revenue share during the forecast period.
Key factors hampering growth of the market include drawbacks of thromboelastography as it cannot identify the individual coagulation factors such as factor VIII, factor IX, and factor X.
Major players operating in the global thromboelastography market include Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner